Crohn's Disease Siberite-2
A Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Participants With Moderately to Severely Active Crohn’s Disease (Siberite-2)
Study Aim
Researchers want to see if RO7790121 works, how well it works and how safe it is.
Eligibility
This study is looking for adults with:
- moderate to severe Crohn’s Disease
- failed standard therapy
What Is Involved
Participants will receive an infusion through the vein followed by subcutaneous injections.
